Used as a key intermediate in the synthesis of fluoroquinolone antibiotics, this compound plays an important role in pharmaceutical development, particularly in creating antimicrobial agents with enhanced activity against resistant bacterial strains. Its structure supports the formation of derivatives that target DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication. It is primarily utilized in research and development settings for designing new anti-infective drugs.